Literature DB >> 10442164

Immune correlates of depression.

M Irwin1.   

Abstract

The relation of depression to immunological assays is complex and variable. However, meta-analyses have demonstrated that depressed subjects are likely to show changes in several immune assays. Depressed subjects are likely to have changes in major immune cell classes with an increase in total white blood cell counts and a relative increase in numbers of neutrophils. However, the relative number of lymphocytes is likely to be reduced in depressed subjects. Depression also appears to be associated with increases in at least one measure of immune activation, although further investigations are clearly needed to replicate these interesting observations. Finally, depression is reliably associated with a suppression of mitogen-induced lymphocyte proliferation and with a reduction of NK activity. Despite the heterogeneity of findings, the effect sizes in the relationship between depression and lymphocyte proliferation and NK activity are large as compared to those observed in other areas of psychological and medical research. Several moderating factors may explain and account for the heterogeneity that has been found in the depression-immune results. Future immunologic studies in depressed subjects are needed to clarify the effects of gender and reproductive hormones on the relation between depression and immunity. Severity of melancholic symptoms and sleep disturbance appear to moderate the immune changes in depression but the biological mechanisms that account for the link between these neurovegetative symptoms and depression are not yet known. Finally, assessment of co-morbidity in depressed subjects deserves an increased focus. Data generated from our laboratory clearly show that assessment of alcohol- and tobacco dependence is critical in the interpretation of immune changes in depressed subjects. The clinical significance of changes in immune responses in depressed subjects remains an unanswered question. Studies that use immune measures with disease specific endpoints, as has been recently conducted in the study of VZV immune responses, would help identify the possible link between depression, immune system alterations, and health outcomes.

Entities:  

Mesh:

Year:  1999        PMID: 10442164     DOI: 10.1007/978-0-585-37970-8_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  22 in total

1.  Inhibition of microglial nitric oxide production by hydrocortisone and glucocorticoid precursors.

Authors:  J Y Chang; L Z Liu
Journal:  Neurochem Res       Date:  2000-07       Impact factor: 3.996

Review 2.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 3.  Inflammation-associated depression: from serotonin to kynurenine.

Authors:  Robert Dantzer; Jason C O'Connor; Marcus A Lawson; Keith W Kelley
Journal:  Psychoneuroendocrinology       Date:  2010-10-30       Impact factor: 4.905

4.  Relationships among functional markers, management, and husbandry in sheep: a Mediterranean case study.

Authors:  F Petazzi; G Rubino; I Alloggio; A Caroli; E Pieragostini
Journal:  Vet Res Commun       Date:  2009-12       Impact factor: 2.459

5.  Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression--evolution of antidepressants and the role of the "neuro-immune" system.

Authors:  János Kálmán; András Palotás; Anna Juhász; Agnes Rimanóczy; Marietta Hugyecz; Zsuzsa Kovács; Gabriella Galsi; Zoltán Szabó; Magdolna Pákáski; Liliána Z Fehér; Zoltán Janka; László G Puskás
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

6.  The detection and treatment of depression in the physically ill.

Authors:  David Goldberg
Journal:  World Psychiatry       Date:  2010-02       Impact factor: 49.548

7.  Antioxidant status and its association with elevated depressive symptoms among US adults: National Health and Nutrition Examination Surveys 2005-6.

Authors:  May A Beydoun; Hind A Beydoun; Adel Boueiz; Monal R Shroff; Alan B Zonderman
Journal:  Br J Nutr       Date:  2012-08-31       Impact factor: 3.718

Review 8.  Biological indicators of suicide risk in youth with mood disorders: what do we know so far?

Authors:  Ute Lewitzka; Sarah Doucette; Florian Seemüller; Paul Grof; Anne C Duffy
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

Review 9.  Inflammatory biomarkers and depression.

Authors:  Norbert Müller; Aye-Mu Myint; Markus J Schwarz
Journal:  Neurotox Res       Date:  2010-07-24       Impact factor: 3.911

10.  Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients.

Authors:  Susan K Lutgendorf; Donald M Lamkin; Koen DeGeest; Barrie Anderson; Minh Dao; Stephanie McGinn; Bridget Zimmerman; Heena Maiseri; Anil K Sood; David M Lubaroff
Journal:  Brain Behav Immun       Date:  2008-02-13       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.